نتایج جستجو برای: ovarian activity

تعداد نتایج: 1209255  

Journal: :Oncotarget 2016
Eun Jung Choi Eun Jin Seo Dae Kyoung Kim Su In Lee Yang Woo Kwon Il Ho Jang Ki-Hyung Kim Dong-Soo Suh Jae Ho Kim

Ovarian cancer has the highest mortality rate of all gynecological cancers with a high recurrence rate. It is important to understand the nature of recurring cancer cells to terminally eliminate ovarian cancer. The winged helix transcription factor Forkhead box P1 (FOXP1) has been reported to function as either oncogene or tumor-suppressor in various cancers. In the current study, we show that ...

2014
Elizabeth R. Smith Ying Wang Xiang-Xi Xu

DESPITE SIGNIFICANT UNDERSTANDING OF THE GENETIC MUTATIONS INVOLVED IN OVARIAN EPITHELIAL CANCER AND ADVANCES IN GENOMIC APPROACHES FOR EXPRESSION AND MUTATION PROFILING OF TUMOR TISSUES, SEVERAL KEY QUESTIONS IN OVARIAN CANCER BIOLOGY REMAIN ENIGMATIC: the mechanism for the well-established impact of reproductive factors on ovarian cancer risk remains obscure; cell of origin of ovarian cancer ...

2016
Natividad Gomez-Roman Neha Mohan Sahasrabudhe Fiona McGregor Anthony J. Chalmers Jim Cassidy Jane Plumb

The small GTPase Rab25 has been functionally linked to tumour progression and aggressiveness in ovarian cancer and promotes invasion in three-dimensional environments. This type of migration has been shown to require the expression of the hypoxia-inducible factor 1 alpha (HIF-1α). In this report we demonstrate that Rab25 regulates HIF-1α protein expression in an oxygen independent manner in a p...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Tatiana M Gritsko Domenico Coppola June E Paciga Lin Yang Mei Sun Sue A Shelley James V Fiorica Santo V Nicosia Jin Q Cheng

Previous studies have demonstrated amplification of the centrosome serine/threonine kinase BTAK/Aurora-A in 10-25% of ovarian cancers. However, alterations of BTAK/Aurora-A at kinase and protein levels and its role in ovarian cancer progression have not been well documented. In this study, we examined the kinase activity and protein levels of BTAK/Aurora-A in 92 patients with primary ovarian tu...

Journal: :Journal of the National Cancer Institute 2003
Yu-Long Hu Chris Albanese Richard G Pestell Robert B Jaffe

BACKGROUND Lysophosphatidic acid (LPA), at concentrations present in ascitic fluid, indirectly stimulates the growth of malignant ovarian tumors by increasing the expression of vascular endothelial growth factor (VEGF) in ovarian cancer cells. We investigated whether LPA could also directly promote ovarian tumor growth by increasing the level of cyclin D1, a key G1-phase checkpoint regulator, w...

2014
Naike Casagrande Marta Celegato Cinzia Borghese Maurizio Mongiat Alfonso Colombatti Donatella Aldinucci

Purpose:Cisplatin and its platinumderivatives are first-line chemotherapeutic agents in the treatment of ovarian cancer; however, treatment is associated with tumor resistance and significant toxicity. Here we investigated the antitumoral activity of lipoplatin, one of the most promising liposomal platinum drug formulations under clinical investigation. Experimental Design: In vitro effects of ...

Journal: :The Biochemical journal 2007
Yuanda Song Palmer Wilkins Wenhui Hu Karnam S Murthy Jing Chen Zendra Lee Regina Oyesanya Jinhua Wu Suzanne E Barbour Xianjun Fang

PLA2 (phospholipase A2) enzymes play critical roles in membrane phospholipid homoeostasis and in generation of lysophospholipid growth factors. In the present study, we show that the activity of the cytosolic iPLA2 (calcium-independent PLA2), but not that of the calcium-dependent cPLA2 (cytosolic PLA2), is required for growth-factor-independent, autonomous replication of ovarian carcinoma cells...

Journal: :Molecular cancer therapeutics 2013
Amir A Jazaeri Etsuko Shibata Jonghoon Park Jennifer L Bryant Mark R Conaway Susan C Modesitt Peter G Smith Michael A Milhollen Allison J Berger Anindya Dutta

The nearly ubiquitous development of chemoresistant disease remains a major obstacle against improving outcomes for patients with ovarian cancer. In this investigation, we evaluated the preclinical activity of MLN4924, an investigational inhibitor of the NEDD8-activating enzyme, in ovarian cancer cells. Efficacy of MLN4924 both alone and in combination with platinum was assessed. Overall, singl...

2013
Amir A. Jazaeri Etsuko Shibata Jonghoon Park Jennifer L. Bryant Mark R. Conaway Susan C. Modesitt Peter G. Smith Michael A. Milhollen Allison J. Berger Anindya Dutta

The nearly ubiquitous development of chemoresistant disease remains a major obstacle against improving outcomes for patients with ovarian cancer. In this investigation, we evaluated the preclinical activity of MLN4924, an investigational inhibitor of the NEDD8-activating enzyme, in ovarian cancer cells. Efficacy of MLN4924 both alone and in combination with platinum was assessed. Overall, singl...

Journal: :Animal reproduction science 2000
M M Al Eknah

The article reviews aspects of the basic reproductive biology of the camel, such as puberty, breeding season, ovarian dynamics, synchronisation of ovarian activity and artificial insemination, and superovulation and embryo transfer. Pregnancy and parturition are also discussed.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید